|
Sutent is available in Canada for the treatment of Metastatic Renal Cell Carcinoma (MRCC) and Gastrointestinal Stromal Tumours (GIST). Sutent is an eligible benefit through most private insurance plans, provincial/ territorial drug benefit programs and federal drug plans. See summary below. More detailed information (including reimbursement criteria, guidelines, claim forms) can be accessed by clicking HERE.
|